• Login
    View Item 
    •   Mak IR Home
    • College of Health Sciences (CHS)
    • School of Medicine (Sch. of Med.)
    • School of Medicine (Sch. of Med.) Collections
    • View Item
    •   Mak IR Home
    • College of Health Sciences (CHS)
    • School of Medicine (Sch. of Med.)
    • School of Medicine (Sch. of Med.) Collections
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    The effect of the Burdizzo castration on serum prostatic specific antigen and testosterone levels in men with prostate cancer

    Thumbnail
    View/Open
    Main article (490.3Kb)
    Abstract (11.81Kb)
    Date
    2011
    Author
    Ibilata, Gorrett
    Metadata
    Show full item record
    Abstract
    Background Bilateral subcapsular orchidectomy has been one of the surgical methods of androgen deprivation treatment in late stage prostate cancer however it is invasive and has been associated with complications such as haematoma, haemorrhage and infection and requires an operating room. The study aims at determining if the Burdizzo castration offers a novel form of incisionless, bloodless surgical androgen deprivation treatment in men with prostate cancer. Methods This case series was conducted in Mulago National Referral and Teaching Hospital on patients with a confirmed histological diagnosis of prostate adenocarcinoma and destined for bilateral subcapsular orchidectomy between August 2009 and March 2011. The Burdizzo castration was performed on patients who satisfied the selection criteria. Prior to the castration the patients had a blood sample taken off for serum TT levels, volume of testis measured, and performance status graded. They were followed up for a period of six weeks on days 3, 7 and42 were testicular volumes were measured, performance status graded, blood samples for serum TT levels and a final PSA level on day 42. Results The mean age of the participants was 70. There was a significant effect on serum PSA with a mean reduction of 119.06ng/ml which was statistically significant (p-value 0.00). The mean change in serum TT levels was 537.2, 393.8 and 83.90ng/ml on day 3, 7 and 42 respectively which was not statistically significant with p-values of 0.8531, 0.3600 and 0.9241 respectively. The testicular volumes reduced to half the original size with a p-value of 0.000. There was an overall improvement in performance status of 70% post castration. The noted side effects were mild pain and scrotal oedema for all the patients with only four having a superficial skin infection noted on day 3. Three patients died before completing the study however the fourth died 6 days after the study. Conclusion The findings suggest that the Burdizzo castration could be an effective safe method of castration as evidenced by the clinical reduction of PSA and testosterone levels, reduction in the size of the testis and improvement of performance status with a few observed side effects. However further evaluation using a randomized controlled trial to establish its efficacy is required and a long term follow up of the patients is needed.
    URI
    http://hdl.handle.net/10570/2852
    Collections
    • School of Medicine (Sch. of Med.) Collections

    DSpace 5.8 copyright © Makerere University 
    Contact Us | Send Feedback
    Theme by 
    Atmire NV
     

     

    Browse

    All of Mak IRCommunities & CollectionsTitlesAuthorsBy AdvisorBy Issue DateSubjectsBy TypeThis CollectionTitlesAuthorsBy AdvisorBy Issue DateSubjectsBy Type

    My Account

    LoginRegister

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    DSpace 5.8 copyright © Makerere University 
    Contact Us | Send Feedback
    Theme by 
    Atmire NV